Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patient.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease.BMJ open gastroenterology · 2019
   Article
2. The assessment and management of pain in cirrhosis.Current hepatology reports · 2018
   Article
3. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications.World journal of hepatology · 2015
   Review
4. Health related management plans improve sleep disorders of patients with chronic liver disease.International journal of clinical and experimental medicine · 2015
   Article

Corrections and comments

• Comment on
  Pain and opioid use in chronic liver disease.2013

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as